Literature DB >> 14991143

The endocrine pharmacology of testosterone therapy in men.

Michael Oettel1.   

Abstract

The review starts off by outlining the history of the discovery of the male sex hormone testosterone and the historical background to the various, often dubious, approaches to the treatment of age-related endocrine disorders in older men. A discussion of congenital androgen deficiency in young men is followed by methods of diagnosing hypogonadism in older men. Among therapeutic options, the alternatives to direct testosterone replacement are discussed, although none of them have proved to be particularly successful in clinical practice. For testosterone replacement itself, various routes of administration and pharmaceutical formulations are now available, facilitating good monitoring and individualized therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991143     DOI: 10.1007/s00114-003-0494-4

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  92 in total

1.  A brief history of testosterone.

Authors:  E R Freeman; D A Bloom; E J McGuire
Journal:  J Urol       Date:  2001-02       Impact factor: 7.450

2.  Inhibition of binding of gonadal steroids to serum binding proteins by non-esterified fatty acids: the influence of chain length and degree of unsaturation.

Authors:  C Street; R J Howell; L Perry; S Al-Othman; T Chard
Journal:  Acta Endocrinol (Copenh)       Date:  1989-02

Review 3.  Andropause: a misnomer for a true clinical entity.

Authors:  A Morales; J P Heaton; C C Carson
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

4.  Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.

Authors:  Sigrid von Eckardstein; Eberhard Nieschlag
Journal:  J Androl       Date:  2002 May-Jun

5.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome.

Authors:  D B Lubahn; D R Joseph; P M Sullivan; H F Willard; F S French; E M Wilson
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

Review 6.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

Authors:  B R Winkelmann; W März; B O Boehm; R Zotz; J Hager; P Hellstern; J Senges
Journal:  Pharmacogenomics       Date:  2001-02       Impact factor: 2.533

7.  Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.

Authors:  Michele Iannuzzi-Sucich; Karen M Prestwood; Anne M Kenny
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-12       Impact factor: 6.053

8.  Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.

Authors:  Colleen Christmas; Kieran G O'Connor; S Mitchell Harman; Jordan D Tobin; Thomas Münzer; Michele F Bellantoni; Carol St Clair; Katharine M Pabst; John D Sorkin; Marc R Blackman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-01       Impact factor: 6.053

Review 9.  Non-genomic actions of sex steroid hormones.

Authors:  Tommaso Simoncini; Andrea R Genazzani
Journal:  Eur J Endocrinol       Date:  2003-03       Impact factor: 6.664

Review 10.  Andropause: an old concept in new clothing.

Authors:  John E Morley; H Mitchell Perry
Journal:  Clin Geriatr Med       Date:  2003-08       Impact factor: 3.076

View more
  6 in total

1.  The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects.

Authors:  Barbara J Attardi; Sheri A Hild; Sailaja Koduri; Trung Pham; Laurent Pessaint; Jean Engbring; Bruce Till; David Gropp; Anne Semon; Jerry R Reel
Journal:  J Steroid Biochem Mol Biol       Date:  2010-06-25       Impact factor: 4.292

Review 2.  Reactive oxygen species: players in the cardiovascular effects of testosterone.

Authors:  Rita C Tostes; Fernando S Carneiro; Maria Helena C Carvalho; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

3.  Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase.

Authors:  Barbara J Attardi; Trung C Pham; Lisa C Radler; Janet Burgenson; Sheri A Hild; Jerry R Reel
Journal:  J Steroid Biochem Mol Biol       Date:  2008-06       Impact factor: 4.292

Review 4.  Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications.

Authors:  Angela K Lucas-Herald; Rheure Alves-Lopes; Augusto C Montezano; S Faisal Ahmed; Rhian M Touyz
Journal:  Clin Sci (Lond)       Date:  2017-07-01       Impact factor: 6.124

5.  Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate.

Authors:  Atheer Zgair; Yousaf Dawood; Suhaib M Ibrahem; Jong Bong Lee; Wanshan Feng; Peter M Fischer; Pavel Gershkovich
Journal:  Molecules       Date:  2021-01-05       Impact factor: 4.411

Review 6.  The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts.

Authors:  Omer Faruk Kirlangic; Didem Yilmaz-Oral; Ecem Kaya-Sezginer; Gamze Toktanis; Aybuke Suveyda Tezgelen; Ekrem Sen; Armagan Khanam; Cetin Volkan Oztekin; Serap Gur
Journal:  Sex Med       Date:  2020-03-20       Impact factor: 2.491

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.